Skip to main content
. 2020 Jan 28;7:100217. doi: 10.1016/j.ejro.2020.01.006

Table 5.

Diagnostic performance expressed as areas under the ROC curve [AUROC, 95 % confidence intervals (CI)], and threshold observed to maximize the sensitivity and specificity determined by ROC analysis to assess the utility of each measure for the detection of mucosal healing. Only significant parameters are listed.

AUROC CI p Threshold Sensitivity (%) Specificity (%) TP TN FP FN Accuracy (%)
Wall thickness post-treatment (mean ± SD, mm) 0.938 0.840-1.000 0.001 <6.5 73.3 100.0 9/24
(37.5)
11/24
(45.8)
4/24
(16.7)
0/24
(0)
83.3
MaRIA post-treatment
(mean ± SD)
0.901 0.766-1.000 0.004 <17.99 77 100 8/21
(38.1)
10/21
(47.6)
3/21
(14.3)
0/21
(0)
85.7
Δ MaRIA (%, mean ± SD) 0.813 0.602-1.000 0.024 <-24.78 77 71.4 7/21
(33.3)
3/21
(14.3)
10/21
(47.6)
1/21
(4.8)
50
Clermont pre-treatment
(mean ± SD)
0.835 0.659-1.000 0.016 <24.02 69.2 100 8/23
(34.8)
9/23
(39.1)
6/23
(26.1)
0
(0)
73.9
Clermont post-treatment
(mean ± SD)
0.912 0.773-1.000 0.003 <9.41 100 71.4 6/23
(26.1)
15/23
(65.2)
0/23
(0)
2/23
(8.7)
91.3

TP: true positive rate; TN: true negative rate; FP: false positive rate; FN: false negative rate, expressed as proportion of patients (percentage).